BAX vs. BMY
Compare and contrast key facts about Baxter International Inc. (BAX) and Bristol-Myers Squibb Company (BMY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BAX or BMY.
Correlation
The correlation between BAX and BMY is 0.46, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
BAX vs. BMY - Performance Comparison
Loading data...
Key characteristics
BAX:
-0.23
BMY:
0.36
BAX:
-0.12
BMY:
0.70
BAX:
0.98
BMY:
1.08
BAX:
-0.12
BMY:
0.20
BAX:
-0.49
BMY:
1.13
BAX:
15.74%
BMY:
8.62%
BAX:
32.85%
BMY:
31.53%
BAX:
-68.86%
BMY:
-70.62%
BAX:
-62.73%
BMY:
-35.93%
Fundamentals
BAX:
$15.93B
BMY:
$95.14B
BAX:
-$0.52
BMY:
$2.73
BAX:
2.00
BMY:
2.26
BAX:
1.48
BMY:
2.00
BAX:
2.25
BMY:
5.36
BAX:
$11.89B
BMY:
$47.64B
BAX:
$4.28B
BMY:
$31.43B
BAX:
$647.00M
BMY:
$16.18B
Returns By Period
In the year-to-date period, BAX achieves a 9.10% return, which is significantly higher than BMY's -15.53% return. Over the past 10 years, BAX has outperformed BMY with an annualized return of -0.07%, while BMY has yielded a comparatively lower -0.58% annualized return.
BAX
9.10%
13.80%
0.05%
-7.58%
-16.67%
-0.07%
BMY
-15.53%
-5.29%
-15.02%
11.19%
-2.62%
-0.58%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
BAX vs. BMY — Risk-Adjusted Performance Rank
BAX
BMY
BAX vs. BMY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Baxter International Inc. (BAX) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
BAX vs. BMY - Dividend Comparison
BAX's dividend yield for the trailing twelve months is around 2.91%, less than BMY's 5.22% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BAX Baxter International Inc. | 2.91% | 3.57% | 3.00% | 2.26% | 1.26% | 1.19% | 1.02% | 1.11% | 0.94% | 1.14% | 0.60% | 0.00% |
BMY Bristol-Myers Squibb Company | 5.22% | 4.24% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% | 2.46% |
Drawdowns
BAX vs. BMY - Drawdown Comparison
The maximum BAX drawdown since its inception was -68.86%, roughly equal to the maximum BMY drawdown of -70.62%. Use the drawdown chart below to compare losses from any high point for BAX and BMY. For additional features, visit the drawdowns tool.
Loading data...
Volatility
BAX vs. BMY - Volatility Comparison
The current volatility for Baxter International Inc. (BAX) is 9.08%, while Bristol-Myers Squibb Company (BMY) has a volatility of 11.57%. This indicates that BAX experiences smaller price fluctuations and is considered to be less risky than BMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
BAX vs. BMY - Financials Comparison
This section allows you to compare key financial metrics between Baxter International Inc. and Bristol-Myers Squibb Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BAX vs. BMY - Profitability Comparison
BAX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Baxter International Inc. reported a gross profit of 861.00M and revenue of 2.63B. Therefore, the gross margin over that period was 32.8%.
BMY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Bristol-Myers Squibb Company reported a gross profit of 8.17B and revenue of 11.20B. Therefore, the gross margin over that period was 72.9%.
BAX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Baxter International Inc. reported an operating income of 58.00M and revenue of 2.63B, resulting in an operating margin of 2.2%.
BMY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Bristol-Myers Squibb Company reported an operating income of 3.52B and revenue of 11.20B, resulting in an operating margin of 31.4%.
BAX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Baxter International Inc. reported a net income of 126.00M and revenue of 2.63B, resulting in a net margin of 4.8%.
BMY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Bristol-Myers Squibb Company reported a net income of 2.46B and revenue of 11.20B, resulting in a net margin of 21.9%.